Prescription Eye Drop Medication Recalled for Subpotency and Contamination
Mylan Pharmaceuticals recalls one lot of Travoprost ophthalmic solution due to subpotency and impurity issues found during stability testing. Patients should consult their pharmacist or physician if they have medication from this lot.
- Product
- TRAVOPROST OPHTHALMIC SOLUTION, 0.004% — TRAVOPROST OPHTHALMIC SOLUTION, 0.004% (TRAVOPROST OPHTHALMIC SOLUTION, 0.004%)
- Category
- Drug
- Distribution
- Distributed nationwide